Literature DB >> 15635538

Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences.

Murali M Chakinala1, Michael J Walter.   

Abstract

Community acquired respiratory viruses (CARVs) are increasingly recognized as serious threats to lung transplant recipients. While CARVs such as respiratory syncytial virus, parainfluenza, influenza, and adenovirus usually cause self-limited illnesses in immunocompetent subjects, infections in the transplant recipient can be dramatic. As transplant recipients live longer and diagnostic methods improve, the burden of CARVs will undoubtedly increase. Because of limited therapeutic options, some patients may succumb to CARV infections, while many survivors develop chronic allograft dysfunction. Recognition of this latter phenomenon has implicated CARVs in the pathogenesis of bronchiolitis obliterans.

Entities:  

Mesh:

Year:  2004        PMID: 15635538     DOI: 10.1053/j.semtcvs.2004.09.015

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  13 in total

1.  IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Authors:  Cassandra L Mikols; Le Yan; Jin Y Norris; Tonya D Russell; Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Roger D Yusen; Mario Castro; Elbert Kuo; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

3.  Chemokine-mediated angiogenesis: an essential link in the evolution of airway fibrosis?

Authors:  Ivor S Douglas; Mark R Nicolls
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.

Authors:  Kari Neemann; Alison Freifeld
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

5.  Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection.

Authors:  David M Sayah; Jonathan L Koff; Lorriana E Leard; Steven R Hays; Jeffrey A Golden; Jonathan P Singer
Journal:  Clin Transplant       Date:  2012-12-30       Impact factor: 2.863

6.  Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients.

Authors:  A Weinberg; D M Lyu; S Li; J Marquesen; M R Zamora
Journal:  Transpl Infect Dis       Date:  2010-04-29       Impact factor: 2.228

Review 7.  Pulmonary infections following lung transplantation.

Authors:  Chad A Witt; Bryan F Meyers; Ramsey R Hachem
Journal:  Thorac Surg Clin       Date:  2012-06-13       Impact factor: 1.750

8.  A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection.

Authors:  Jorge Garbino; Sophie Crespo; J-D Aubert; Thierry Rochat; Beatrice Ninet; Christelle Deffernez; Werner Wunderli; Jean-Claude Pache; Paola M Soccal; Laurent Kaiser
Journal:  Clin Infect Dis       Date:  2006-09-13       Impact factor: 9.079

Review 9.  Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation.

Authors:  Dana J Hawkinson; Michael G Ison
Journal:  Semin Nephrol       Date:  2016-09       Impact factor: 5.299

10.  Respiratory syncytial virus pneumonia treated with lower-dose palivizumab in a heart transplant recipient.

Authors:  J L Grodin; K S Wu; E E Kitchell; J Le; J D Mishkin; M H Drazner; D W Markham
Journal:  Case Rep Cardiol       Date:  2011-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.